VITA 34 International AG: Clear plus in revenue and EBIT in the first nine months of 2010

VITA 34 International AG  / Key word(s): Quarter Results

14.10.2010 07:45

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

VITA 34 International AG: Clear plus in revenue and EBIT in the first
nine months of 2010

* EBIT rises from 0.1m Euro to 0.4m Euro
* Storages of 8,293 above last year's level of 8,105
* Revenue increased by almost eight percent to 12.0m Euro
* Total annual forecast confirmed

Leipzig, October 14, 2010 - The VITA 34 International AG (ISIN
DE000A0BL849), parent company of the largest private umbilical cord blood
bank in the German-speaking countries, VITA 34 AG, has successfully
continued its growth strategy in the first nine months of 2010. Cost
reduction measures and the development of business in Spain among other
things have led to an improvement of the earnings before interest and taxes
(EBIT) to approximately 0.4m Euro, compared to 0.1m Euro for the same
period in the previous year. The sales revenues climbed from 11.1m Euro to
12.0m Euro. The number of storages of umbilical cord blood of 8,293
exceeded last year's high level of 8,105.

The corporate result of 0.2m Euro in the period under review in 2010 was
slightly lower than the 0.4m Euro in the same period of the previous year,
which included a special item from the discontinued operations though.
The equity capital increased to 18.8m Euro as per September 30, 2010,
compared to 18.6m Euro as per September 30, 2009. Within the scope of the
takeover of Secuvita in May 2010, the liquid assets decreased to 4.7m Euro
as per the end of September 2010, compared to 7.7m Euro the year before.

As regards the total year 2010, VITA 34 continues to be on target to
distinctly improving the profitability and increasing the revenue to 17 to
18m Euro from about 15m Euro in the business year 2009. The successful
foreign business is to contribute a considerable share to these goals.

The complete nine months report is available for download at
www.vita34group.com.


Press/Investor Relations:

Axel Mühlhaus
Dr. Sönke Knop
edicto GmbH
Eschersheimer Landstr. 42-44
D-60322 Frankfurt

Phone.:+49 (069) 90550550
Fax: +49 (069) 90550577
e-mail: vita34@edicto.de






14.10.2010 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      VITA 34 International AG
              Deutscher Platz 5a
              04103 Leipzig
              Deutschland
Phone:        +49(0341)48792-40
Fax:          +49(0341)48792-39
E-mail:       info@vita34.de
Internet:     www.vita34.de
ISIN:         DE000A0BL849
WKN:          A0BL84
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Hamburg, München, Berlin, Düsseldorf, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------